InsiderTrades

Form 4 for IBRX ImmunityBio, Inc.

Accepted 2024-12-12 00:00:00 ET · period of report 2024-12-10 · accession 0001326110-24-000117 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DMI 2024-12-12 2024-12-10 IBRX CALIFORNIA CAPITAL EQUITY, LLC 10% C - Cnv Deriv $1.98 +117.19M 246.41M +91% +$231.92M
DMI 2024-12-12 2024-12-10 IBRX CALIFORNIA CAPITAL EQUITY, LLC 10% C - Cnv Deriv — 0 0 New —
DMI 2024-12-12 2024-12-10 IBRX CALIFORNIA CAPITAL EQUITY, LLC 10% J - Other — 0 0 New —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-12-10 C A 103,710,088 $1.94 232,937,105 I See footnote — — (F1) Shares held by Nant Capital, LLC, an investment vehicle of the reporting person ("Nant Capital").
2 Common Common Stock 2024-12-10 C A 13,475,172 $2.28 246,412,277 I See footnote — — (F1) Shares held by Nant Capital, LLC, an investment vehicle of the reporting person ("Nant Capital").
3 Derivative Convertible Promissory Note 2024-12-10 C D — $0.00 0 I See footnote $1.94 · — to 2026-09-11 103,710,088 Common Stock (F11) Convertible Promissory Note held by Nant Capital. (F10) That date upon which an amendment to the Issuers Certificate of Incorporation, as amended, becomes effective pursuant to which the number of authorized shares of the Issuer's common stock is increased from 900,000,000 to 1,350,000,000.
4 Derivative Second Amended and Restated Convertible Promissory Note 2024-12-10 J A — $505,000,000.00 505,000,000 I See footnote $5.43 · 2024-12-10 to 2027-12-31 — Common Stock (F15) The Consolidated Note held by Nant Capital.
5 Derivative Convertible Promissory Note 2024-12-10 C D — $0.00 0 I See footnote $2.28 · 2023-05-12 to 2025-12-31 13,475,172 Common Stock (F11) Convertible Promissory Note held by Nant Capital.
6 Derivative Amended and Restated Promissory Note 2024-12-10 J D — $0.00 0 I See footnote $8.27 · 2023-12-29 to 2025-12-31 — Common Stock (F14) Amended and Restated Convertible Promissory Note held by Nant Capital.